Levels of small extracellular vesicles in patients treated with hyperbaric oxygenation

Authors: Jacek Siewiera, Michał Smoleński, Natalia Jermakow, Jacek Kot, Torsten E. Reichert, Piotr Miśkiewicz, Łukasz Zaręba, Anna Cyran, Mirosław J. Szczepański, Nils Ludwig

Source: Archives of Medical Science, Vol 20, Iss 2, Pp 476-484 (2023)

Subject Terms: exosomes, hyperbaric oxygen therapy, small extracellular vesicles, necrotizing soft-tissue infections, aseptic bone necrosis, idiopathic sudden sensory neural hearing loss, Medicine

File Description: electronic resource

Relation: https://www.archivesofmedicalscience.com/Levels-of-small-extracellular-vesicles-in-patients-treated-with-hyperbaric-oxygenation,169382,0,2.html; https://doaj.org/toc/1734-1922; https://doaj.org/toc/1896-9151

Access URL: https://doaj.org/article/5c8655d865d840a69e35184e9a73a01a

Development of the method for the pharmaceutical availability testing of clotrimazole from multiphase semi-solid vaginal dosage forms

Authors: Michał Smoleński, Dorota Haznar-Garbacz, Susanne Florin-Muschert, Katarzyna Małolepsza-Jarmołowska

Source: Farmacja Polska, Vol 78, Iss 12, Pp 675-684 (2023)

Subject Terms: vagina, dissolution, clotrimazole, nanoemulsion, dosage forms, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F12%2F01_OG_Clotrimazol_n.pdf; https://doaj.org/toc/0014-8261

Access URL: https://doaj.org/article/df240929f71f4e178ddee6ed29a281f7

Nanoemulsion Loaded with Clotrimazole Based on Rapeseed Oil for Potential Vaginal Application—Development, Initial Assessment, and Pilot Release Studies

Authors: Michał Smoleński, Susanne Muschert, Dorota Haznar-Garbacz, Katarzyna Małolepsza-Jarmołowska

Source: Pharmaceutics, Vol 15, Iss 5, p 1437 (2023)

Subject Terms: nanoemulsion, clotrimazole, vaginal drug carriers, vaginal candidiasis, EVDF, vaginal drug delivery, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1999-4923/15/5/1437; https://doaj.org/toc/1999-4923

Access URL: https://doaj.org/article/b0dd9a22db654f35953fb5a3f41a8314

Development and Evaluation of Lactose-Free Single-Unit and Multiple-Unit Preparations of a BCS Class II Drug, Rivaroxaban

Authors: Daniel Zakowiecki, Peter Edinger, Markos Papaioannou, Michael Wagner, Tobias Hess, Jadwiga Paszkowska, Marcela Staniszewska, Daria Myslitska, Michal Smolenski, Justyna Dobosz, Grzegorz Garbacz, Dorota Haznar Garbacz

Source: Pharmaceutics, Vol 16, Iss 11, p 1485 (2024)

Subject Terms: rivaroxaban, lactose-free formulation, excipient, calcium phosphates, pellets, MUPS, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1999-4923/16/11/1485; https://doaj.org/toc/1999-4923

Access URL: https://doaj.org/article/be3cd09a86c64588bf6c844079d2c974